Clinical Trials Directory

Trials / Unknown

UnknownNCT00773123

Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
10 Years – 90 Years
Healthy volunteers
Accepted

Summary

RT-View utilizes spectral domain technology to assess both RNFL and ganglion cell layer thickness. This study aims to correlate visual field defects in patients with glaucoma to both RNFL and ganglion cell layer thickness.

Conditions

Timeline

Start date
2008-10-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2008-10-16
Last updated
2008-10-16

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00773123. Inclusion in this directory is not an endorsement.